Liver-function decompensation or hepatocellular carcinoma (HCC) gradually appears after chronic hepatitis B progresses to cirrhosis. Effective antiviral treatment can significantly improve the long-term prognosis of decompensated patients, and some patients present recompensation of decompensated hepatitis B cirrhosis. At present, there are limited research data on the recompensation of decompensated hepatitis B cirrhosis. There is still controversy regarding the evaluation time, evaluation indicators, influencing factors, and long-term prognosis of recompensation.

中文翻译：

---

失代偿性乙型肝炎肝硬化的补偿：现状和挑战

慢性乙型肝炎发展为肝硬化后，肝功能失代偿或肝细胞癌（HCC）逐渐出现。有效的抗病毒治疗可以显着改善失代偿患者的长期预后，并且一些患者可以弥补失代偿的乙型肝炎肝硬化。目前，关于代偿失调的乙型肝炎肝硬化的补偿的研究数据有限。关于评估时间，评估指标，影响因素以及补偿的长期预后仍存在争议。